In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

Tauangtham Anekpuritanang, Matthew M. Klairmont, Joel Gradowski, Kohei Hagiwara, Nathanael G. Bailey, Pranil Chandra, Yiwei Liu, Heather L. Mulder, John Easton, Jinghui Zhang, Michael G. Martin, Anna B. Owczarczyk, Jennifer B. Dunlap, Guang Fan, Richard D. Press, Philipp W. Raess

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)5057-5059
Number of pages3
JournalBlood Advances
StatePublished - Dec 14 2021

ASJC Scopus subject areas

  • Hematology

Cite this